NCT01087151 2016-11-02A Study of ABT-263 in Combination With Dose-Intensive Rituximab, or Dose-Intensive Rituximab Alone, in Previously Untreated Patients With B-Cell, Chronic Lymphocytic Leukemia (CLL)Genentech, Inc.Phase 2 Completed118 enrolled